Table 1.
Subjects with prenatal DES exposure n (%) or mean (S.D.) (n=1680) | Siblings without prenatal DES exposure n (%) or mean (S.D.) (n=1447) | |
---|---|---|
Demographic characteristics | ||
Duration of follow-up (years)a | 36.8 (7.4) | 36.5 (5.5) |
Male gender | 751 (44.7)) | 781 (54.0 |
Educational level >14 years | 1189 (71.8) | 952 (67.2) |
Obstetric history | ||
Definite obstetric complicationb | 1331 (79.2) | 561 (38.8) |
Prenatal exposure to progestagen | 632 (37.6) | 281 (19.4) |
Prenatal exposure to other hormones | 87 (5.2) | 75 (5.2) |
History of maternal or paternal psychiatric hospitalization | 74 (4.4) | 61 (4.2) |
DES, Diethylstilboestrol; S.D., standard deviation.
Age of the children still alive in 2004, or age at the time of death.
At least one definite obstetric complication according to the Lewis and Murray scale (Lewis & Murray, 1987): threatened abortion; antepartum bleeding; severe hypertension requiring hospitalization; caesarean for emergency delivery; breech presentation; premature birth >3 weeks; postmature birth >2 weeks; birthweight <2000 g; incubator used >4 weeks.